Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

How Much Does Time Since Quitting and Amount Smoked Matter for LC Risk?
Dr West
Author
Howard (Jack) West, MD

Though the topic of never-smokers with lung cancer is a particular focus of my interest and research, and there has been a greater focus on this topic in the last few years, most lung cancer is still related to smoking. However, we have clearly reached a point where the majority of people diagnosed with lung cancer are not current smokers at the time of their diagnosis, and about 60% have quit at some point. Many of these patients, and their families and friends, express surprise that they developed lung cancer, especially if someone had quit 20 or 30 years prior. How much does the risk for developing lung cancer decline over time, and does the amount smoked before quitting make a difference?

The short answer is that, as you would probably expect, smoking more "pack-years" (the product of average number of packs of cigarettes smoked per day X number of years smoking) is associated with a higher risk than smoking fewer, and that the risk of lung cancer declines over time but doesn't get to the level of a never-smoker (which we know isn't zero risk of lung cancer either). To illustrate, here are the "case-control" results that compare the smoking histories of 521 patients with lung cancer to over 76 thousand people without lung cancer in western Washington state (abstract here):

VITAL results and smoking history (click to enlarge)

The table highlights the following conclusions:

1) Over 60% of lung cancer is diagnosed in former smokers.

2) The lung cancer population appears to be skewed toward current smokers and ex-smokers as over-represented vs. people without LC, and more who quite within the last decade

3) The number of pack-years is greater in patients who developed lung cancer, both among current and former smokers.

But research does clearly indicate that there is a value to quitting, and quitting as early as possible (and that it's never too late). For instance, research from the behavior of over 34,000 British physicians (see full article here, which is very complex and full of details) revealed that smoking is associated with a reduction in survival of about 10 years on average and that the the earlier a person quit smoking, the less of a negative impact smoking had on their survival:

Doll Quitting Cigarrettes Improves Survival

The same themes are supported by another study that characterized the relative risk of lung cancer based on how much a person had smoked and when they quit (relative risk being the likelihood of developing LC compared with a never-smoker, so a relative risk of 5 is 5 times the rate of LC development seen in never-smokers) (abstract here). Specifically, the risk of LC is still quite high within the first five years, especially among those patients who have smoked extensively, but the risk declines steadily over time, regardless of how much someone had smoked before quitting. And while risk never gets down to never-smoker levels, the risk of LC declines toward that ballpark after a few decades.

Declining RR of LC with time after quitting tobacco

Interestingly, one thing that is observed is that there can be a higher rate of lung cancer seen in people who just quit smoking in the previous year. This isn't really because quitting smoking causes lung cancer, but rather almost certainly because a person with undiagnosed lung cancer may experience symptoms that finally motivate them to quit, but the symptoms continue, with a diagnosis made a few months after the person quit smoking.

Overall, this work is consistent in saying that the risk conferred by smoking cannot be completely undone, but that the risk of LC declines with time since quitting, along with an improvement in overall survival compared to continuing to smoke (related to a wide range of tobacco-related detrimental effects on health). Although there's no question that it's hard thing to do, it's never too late to quit.

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

It is so good to hear from you!  And I am so happy to hear that your holidays have been good and that you are doing well.  It sounds like your...

Recent Comments

JOIN THE CONVERSATION
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
Hi Stan!! and happiest of holidays!
By dbrock on